The Drug Discovery and Nanomedicine program was designed to bridge the gap between academic research and translational applications. Our program is part of the Department of Translational Neurosciences and Neurotherapeutics.
We have strong support from the chair of the Neurosciences and Neurotherapeutics department, Dr. Santosh Kesari, and his research team, who assist with a variety of drug efficacy studies during the lead optimization process. Our laboratory is specifically designed for drug discovery and nanomedicine research operations, and allows multi-disciplinary collaboration. Our laboratories are fully equipped with advanced instruments to maximize the quality and productivity. Additionally, our program maintains rigorous collaborations with industry-leading CRO’s and academic institutions.
Current Research Topics
Introduction to Drug repurposing for Rare Diseases
Developing new drugs through the traditional drug development process is expensive, and can take decades to generate a viable treatment. Drug repurposing is the practice of finding new therapeutic indications for existing drugs, and represents a great opportunity to treat rare diseases.
Development of nanocarriers for cancer-targeted drug delivery
Both chemotherapy and targeted therapeutic agents have displayed significant shortcomings in clinical settings, such as systemic toxicities and chemical resistance. Drug carriers are able to overcome those shortcomings and improve the therapeutic index of anti-cancer agents.